Alphatec Holdings Files Q3 2024 10-Q

TL;DR

Alphatec Holdings filed its Q3 2024 10-Q. Check financials.

AI Summary

Alphatec Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers financial information and business operations for the third quarter of 2024. Key financial data and operational details are presented within this report.

Why It Matters

This 10-Q filing provides crucial financial and operational insights into Alphatec Holdings' performance for the third quarter of 2024, impacting investor decisions and market perception.

Risk Assessment

Risk Level: medium — As a medical device company, Alphatec Holdings operates in a highly regulated industry with significant market and product development risks.

Key Numbers

• Q3 2024 — Reporting Period (Financials for the third quarter of 2024 are detailed.)
• 2024-09-30 — Period End Date (The 10-Q covers financial data up to this date.)

Key Players & Entities

• Alphatec Holdings, Inc. (company) — Filer of the 10-Q
• 2024-09-30 (date) — End of the reporting period
• 2024-10-30 (date) — Filing date
• 5818 EL CAMINO REAL, CARLSBAD, CA 92008 (address) — Company's business and mailing address

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share ATEC The NASDAQ Global Se

Filing Documents

• atec-20240930.htm (10-Q) — 1986KB
• atec-ex10_1.htm (EX-10.1) — 91KB
• atec-ex10_2.htm (EX-10.2) — 79KB
• atec-ex31_1.htm (EX-31.1) — 13KB
• atec-ex31_2.htm (EX-31.2) — 13KB
• atec-ex32.htm (EX-32) — 18KB
• 0000950170-24-119083.txt ( ) — 8602KB
• atec-20240930.xsd (EX-101.SCH) — 1214KB
• atec-20240930_htm.xml (XML) — 1429KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Comprehensive Loss 5 Condensed Consolidated Statements of Stockholders' (Deficit) Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 30 Item 1A.

Risk Factors

Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30 Item 5. Other Information 30 Item 6. Exhibits 31

SIGNATURES

SIGNATURES 32 2 Table of Contents

FINANCI AL INFORMATION

PART I. FINANCI AL INFORMATION

Financ ial Statements

Item 1. Financ ial Statements ALPHATEC HOLDINGS, INC. CONDENSED CONSOLIDA TED BALANCE SHEETS (In thousands, except for par value data) September 30, 2024 December 31, 2023 Assets (Unaudited) Current assets: Cash and cash equivalents $ 80,976 $ 220,970 Accounts receivable, net of allowances of $ 4,767 and $ 910 , respectively 78,452 72,613 Inventories 183,111 136,842 Prepaid expenses and other current assets 19,886 20,666 Total current assets 362,425 451,091 Property and equipment, net 171,430 149,835 Right-of-use assets 37,015 26,410 Goodwill 73,397 73,003 Intangible assets, net 98,785 102,451 Other assets 2,843 2,418 Total assets $ 745,895 $ 805,208 Liabilities and Stockholders' (Deficit) Equity Current liabilities: Accounts payable $ 59,578 $ 48,985 Accrued expenses and other current liabilities 76,262 87,712 Contract liabilities 11,602 13,910 Short-term debt 1,790 1,808 Current portion of operating lease liabilities 6,989 5,159 Total current liabilities 156,221 157,574 Long-term debt 525,935 511,035 Operating lease liabilities, less current portion 29,140 23,677 Other long-term liabilities 12,358 11,203 Commitments and contingencies (Note 9) Redeemable preferred stock, $ 0.0001 par value; 20,000 shares authorized at September 30, 2024 and December 31, 2023; 3,319 shares issued and outstanding at September 30, 2024 and December 31, 2023 23,603 23,603 Stockholders' (deficit) equity: Common stock, $ 0.0001 par value; 200,000 authorized; 143,907 shares issued and outstanding at September 30, 2024; and 139,257 shares issued and 139,245 shares outstanding at December 31, 2023 14 14 Treasury stock, 1,808 shares, at cost ( 25,097 ) ( 25,097 ) Additional paid-in capital 1,279,886 1,230,484 Accumulated other comprehensive loss ( 8,412 ) ( 8,323 ) Accumulated deficit ( 1,247,753

View Full Filing

View this 10-Q filing on SEC EDGAR